FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17487811000001102: Pazopanib hydrochloride (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    60323501000001111 Pazopanib hydrochloride (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    60323601000001110 Pazopanib hydrochloride en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Pazopanib hydrochloride Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Pazopanib 200mg tablets 30 tablet Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Votrient 200mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Votrient 400mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Pazopanib 400mg tablets 30 tablet Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier
    Votrient 400mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient False Pazopanib hydrochloride Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start